The Personal Care Product Safety Act
The federal law designed to guarantee the safety of personal care products has remained largely unchanged since 1938. With the exception of color additives, the Food and Drug Administration lacks the power and resources to review the safety of chemicals in cosmetics before they are used.
Under current law, cosmetic companies do not have to register with FDA, submit cosmetic ingredient statements, adopt good manufacturing practices, provide access to safety records or report serious adverse events like hospitalization when they occur.
FDA also lacks the authority to quickly suspend production or recall contaminated products when a company fails to initiate a voluntary recall. By contrast, food, prescription drug, over-the-counter drug, and medical device manufacturers are subject to almost all of these basic consumer protection rules.
The Personal Care Products Safety Act, a bipartisan bill introduced by Sens. Dianne Feinstein (D-Calif.) and Susan Collins (R-Maine), would modernize how FDA regulates personal care products, requiring companies to make sure their products are safe before marketing them, and giving FDA the tools it needs to protect the public.